230 related articles for article (PubMed ID: 24074528)
1. Tailored central nervous system-directed treatment strategy for isolated CNS recurrence of adult acute myeloid leukemia.
Zheng C; Liu X; Zhu W; Cai X; Wu J; Sun Z
Hematology; 2014 Jun; 19(4):208-12. PubMed ID: 24074528
[TBL] [Abstract][Full Text] [Related]
2. The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.
Sanders KE; Ha CS; Cortes-Franco JE; Koller CA; Kantarjian HM; Cox JD
Cancer; 2004 May; 100(10):2176-80. PubMed ID: 15139061
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
[TBL] [Abstract][Full Text] [Related]
4. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
Castagnola C; Nozza A; Corso A; Bernasconi C
Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
6. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
[TBL] [Abstract][Full Text] [Related]
7. Outcome of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with central nervous system involvement.
Aoki J; Ishiyama K; Taniguchi S; Fukuda T; Ohashi K; Ogawa H; Kanamori H; Eto T; Iwato K; Sakamaki H; Morishima Y; Nagamura T; Atsuta Y; Takami A
Biol Blood Marrow Transplant; 2014 Dec; 20(12):2029-33. PubMed ID: 25196856
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults.
Cheng CL; Li CC; Hou HA; Fang WQ; Chang CH; Lin CT; Tang JL; Chou WC; Chen CY; Yao M; Huang SY; Ko BS; Wu SJ; Tsay W; Tien HF
BMC Cancer; 2015 May; 15():344. PubMed ID: 25934556
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia.
Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
J Clin Oncol; 2005 Dec; 23(36):9172-8. PubMed ID: 16361619
[TBL] [Abstract][Full Text] [Related]
10. Current management and challenges of malignant disease in the CNS in paediatric leukaemia.
Pui CH; Howard SC
Lancet Oncol; 2008 Mar; 9(3):257-68. PubMed ID: 18308251
[TBL] [Abstract][Full Text] [Related]
11. Very late isolated CNS relapse of acute myeloid leukemia.
Molina B; Lassaletta A; Gonzalez-Vicent M; Andión M; Diaz MA; Madero L
J Pediatr Hematol Oncol; 2013 Mar; 35(2):e57-9. PubMed ID: 23412589
[TBL] [Abstract][Full Text] [Related]
12. Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate.
Pfeifer H; Wassmann B; Hofmann WK; Komor M; Scheuring U; Brück P; Binckebanck A; Schleyer E; Gökbuget N; Wolff T; Lübbert M; Leimer L; Gschaidmeier H; Hoelzer D; Ottmann OG
Clin Cancer Res; 2003 Oct; 9(13):4674-81. PubMed ID: 14581336
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups.
Creutzig U; Dworzak MN; Zimmermann M; Reinhardt D; Sramkova L; Bourquin JP; Hasle H; Abrahamsson J; Kaspers G; van den Heuvel MM; Reedijk AMJ; De Moerloose B; Locatelli F; Masetti R
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598536
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system relapse in adults with acute lymphoblastic leukemia.
Surapaneni UR; Cortes JE; Thomas D; O'Brien S; Giles FJ; Koller C; Faderl S; Kantarjian H
Cancer; 2002 Feb; 94(3):773-9. PubMed ID: 11857312
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.
Reman O; Pigneux A; Huguet F; Vey N; Delannoy A; Fegueux N; de Botton S; Stamatoullas A; Tournilhac O; Buzyn A; Charrin C; Boucheix C; Gabert J; Lhéritier V; Vernant JP; Fière D; Dombret H; Thomas X;
Leuk Res; 2008 Nov; 32(11):1741-50. PubMed ID: 18508120
[TBL] [Abstract][Full Text] [Related]
16. CNS-directed therapy in young children with T-lineage acute lymphoblastic leukemia: High-dose methotrexate versus cranial irradiation.
Nathan PC; Maze R; Spiegler B; Greenberg ML; Weitzman S; Hitzler JK
Pediatr Blood Cancer; 2004 Jan; 42(1):24-9. PubMed ID: 14752790
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma.
Tomita N; Kodama F; Kanamori H; Motomura S; Ishigatsubo Y
Cancer; 2002 Aug; 95(3):576-80. PubMed ID: 12209750
[TBL] [Abstract][Full Text] [Related]
18. The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse.
Unal S; Yetgin S; Cetin M; Gümrük F; Arslan D; Ozyürek E; Tuncer M; Topçu M
Pediatr Hematol Oncol; 2004; 21(3):279-89. PubMed ID: 15202168
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.
Nagler A; Rocha V; Labopin M; Unal A; Ben Othman T; Campos A; Volin L; Poire X; Aljurf M; Masszi T; Socie G; Sengelov H; Michallet M; Passweg J; Veelken H; Yakoub-Agha I; Shimoni A; Mohty M
J Clin Oncol; 2013 Oct; 31(28):3549-56. PubMed ID: 23980086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]